简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

心脏测试实验室GAAP每股收益为-2.64美元,相差0.18美元

2024-09-13 04:50

  • Heart Test Laboratories press release (NASDAQ:HSCS): Q1 GAAP EPS of -$2.64 misses by $0.18.
  • Cash and cash equivalents of $4.3 million and shareholder’s equity of $5.9 million. Subsequent to the quarter end, the Company further strengthened its balance sheet by extending its cash runway with the closing of $1.9 million, net proceeds, in non-dilutive financing through an 18-month loan note and the 12-month extension of a $500,000 loan note to September 2025.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。